DUFU LIQUOR GP (00986): Dr. Liao Wenjian Appointed as Subsidiary CEO to Lead Company's RWA Business Division and Value Innovation Operations

Stock News
Sep 12

DUFU LIQUOR GP (00986) announced that effective September 12, 2025, Dr. Liao Wenjian has been appointed as Chief Executive Officer of the company's subsidiary. He will be responsible for conducting feasibility studies on the proposed Real World Assets (RWA) and related digital assets business development, integration with the group's existing operations, and business development directions, as well as providing specific planning for related business expansion and implementation.

Dr. Liao Wenjian currently serves as Chairman of Blue Source Capital and Executive Dean of Beijing Blue Source National Industry Research Institute, with twenty years of deep experience in industry chain vertical investment, industry chain integration, and capital investment. Dr. Liao possesses extensive expertise in industrial research and capital operations, with profound insights into the development trends, policy directions, and market opportunities in the global Real World Assets tokenization (RWA) sector.

The company believes that Dr. Liao will leverage his substantial accumulation of relevant industrial resources and capital market operational experience to comprehensively lead the company's RWA business division and value innovation operations. This appointment aims to drive the company to become a professional service provider in the global Real World Assets tokenization (RWA) field, helping the company deepen its understanding and assist the group's future expansion in this sector.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10